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1. Introduction 
The mitochondrial carriers are intrinsic proteins of the 
inner membranes of mitochondria that catalyze the trans- 
port of metabolites across the membrane and are necessary 
not only for oxidative phosphorylation but also for all the 
metabolic pathways, whose enzymes are partitioned be- 
tween the intra- and the extramitochondrial space. So far, 
ten mitochondrial carriers (seven of which in our labora- 
tory) have been purified and functionally reconstituted into 
liposomes (for reviews see [1,2]). These transporters are 
the uncoupling protein from brown fat and the ADP/ATP, 
phosphate, oxoglutarate, citrate, dicarboxylate, pyruvate, 
carnitine, aspartate/glutamate ndornithine carriers. The 
primary structure of the first five of these biochemically 
characterized transporters has been determined by amino 
acid analysis or DNA sequencing (for a review see [1]). 
These proteins are made up of three related sequences 
about 100 amino acids in length. Each repetitive lement 
contains two hydrophobic stretches eparated by an exten- 
sive hydrophilic region. Furthermore, the repeats of each 
protein are related to those present in the others. The 
tripartite structure, the presence of the two hydrophobic 
regions in each domain and the three-fold repetition of a 
particular sequence motif show that these five mitochon- 
drial carriers belong to a single carrier protein family, 
evolved from a common ancestor by two-tandem gene 
duplication. The characteristic sequence features of the 
above-mentioned mitochondrial carriers have also been 
found in a number of other proteins of known sequence 
but of unknown function, which are therefore included in 
the same protein family (for a review see [1]). By examina- 
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tion of the transmembrane topography of the phosphate 
carrier, the oxoglutarate carrier and the uncoupling protein, 
it has been shown that the N-terminal and the C-terminal 
regions of these carriers protrude toward the cytosol and 
their polypeptide chain spans the membrane an even num- 
ber of times in agreement with the six-helix model pro- 
posed for the folding of the ADP/ATP carrier (for a 
review see [1]). In this paper we report the results of our 
recent studies on several structural and functional aspects 
of five previously purified mitochondrial carriers. 
2. cDNA cloning and primary structure of the carnitine 
carrier 
Protein sequencing of the purified carnitine carrier 
(CAC) prepared according to Indiveri et al. [3] has failed 
to reveal an N-terminal sequence, and therefore it appears 
that the a-amino group of the protein is modified. On the 
basis of partial internal protein sequences, mixtures of 
oligonucleotides were used as primers and probes in at- 
tempts to isolate clones encoding the carrier from a rat 
liver cDNA library. Overlapping cDNA clones have been 
obtained that encode the entire sequence of a protein (301 
amino acids long) belonging to the mitochondrial carrier 
family. As with other members of the family, the protein 
sequence contains three tandem repeats of related se- 
quences. Furthermore, these repeats are related to those 
found in the ADP/ATP, phosphate, oxoglutarate and cit- 
rate carriers, and in the uncoupling protein. These results 
demonstrate hat the CAC is a member of the mitochon- 
drial carrier family. This idea was questioned in the past, 
because kinetic data, performed in liposomes reconstituted 
with the purified CAC, had shown that this carrier follows 
a ping-pong mechanism [4] at variance with all the other 
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reconstituted mitochondrial carriers kinetically charac- 
terized so far, that have all been found to function accord- 
ing to a simultaneous ( equential) type of mechanism (for 
Refs. see Refs. [1] and [2]). 
3. Isoforms A and B of the phosphate carrier are 
tissue-specific and functionally different 
A single gene for the phosphate carrier (PiC) has been 
found in human and bovine genomes [5]. This gene has 
been localized to human chromosome 12q23 by fluores- 
cence in situ hybridisation using a clone of about 15 kb 
encompassing the entire PiC gene [6]. The most striking 
feature, uncovered by the comparison of the human and 
bovine genomic sequences with the corresponding cDNAs 
of the PiC, was that both genes contain evidence of 
alternative splicing [5]. Thus, in both genes two exons, 
named III A and III B, are closely related and they appear 
to be alternatively spliced. Evidence that an alternative 
splicing of the PiC gene indeed occurs in man was ob- 
tained by characterization f cDNA clones from a human 
heart cDNA library. Thus, we found two cDNA containing 
only exon IIIA and one cDNA containing only exon IIIB 
[5,7]. The two alternatively spliced isoforms (A and B) 
differ in 13 (man) and 11 (cow) amino acids in the 
N-terminal region of the mature PiC protein, precisely in 
the segment between amino acids 4-45, which is believed 
to form the first of the six transmembrane e~-helices of the 
PiC and to emerge into the first extensive xtramembrane 
loop. In order to investigate the tissue distribution of the 
two transcripts of the PiC gene in cow by Northern blot 
analysis, we have synthesized two probes specific for 
bovine exon I I IA  and exon III B, respectively, by amplify- 
ing two stretches of these exons (that were as long and as 
divergent as possible) on two bovine cDNA corresponding 
to the mature isoforms A and B (i.e., containing exon III A 
and exon III B respectively). The Northern blots were 
performed on total RNAs derived from bovine heart, skele- 
tal muscle, liver, kidney, thyroid and lung. Transcript B 
was expressed in all the tissues tested although at different 
levels. By contrast, transcript A was expressed very 
strongly only in heart and skeletal muscle. With probe A 
no hybridisation was observed in the case of the other 
tissues tested. The distribution of the PiC isoforms A and 
B in mitochondria of various bovine tissues was investi- 
gated by Western blot analysis using anti-peptide antibod- 
ies that were specific for isoforms A and B. The anti-A 
antibody immunodecorated the PiC protein in SDS lysates 
of mitochondria from heart, diaphragm and skeletal mus- 
cle. With this antibody immunoreactivity could not be 
detected in mitochondrial lysates of liver, kidney, brain 
and lung. In contrast, the anti-B antibody immunodeco- 
rated the PiC in mitochondrial lysates from all the tissues 
investigated. These results clearly demonstrate the exis- 
tence of two different isoforms of the PiC both at the 
messenger RNA level and also at the protein level. In 
order to investigate whether the two isoforms of the PiC 
are functionally different, the two bovine cDNAs corre- 
sponding to the mature isoforms A and B were cloned in a 
pET21b vector and over-expressed in Escher ich ia  col i  
cells (BL21(DE3)). The two expressed PiCs carrying a 
histidine tail at their C-terminus were purified onto a 
Ni-agarose affinity column and reconstituted into lipo- 
somes. Transport experiments in the reconstituted system 
showed that isoforms A and B possess the same substrate 
specificity and the same inhibitor sensitivity but they differ 
in the kinetic parameters. The maximal activity (Vm~ ×) of 
isoform B was 2-3 times higher than that of isoform A, 
whereas the half-saturation transport constant (K m) for 
phosphate of isoform B was 3 times lower than that of 
isoform A. These functional differences and the different 
levels of expression of the two isofornls in the various 
tissues (e.g., the high amount of the less active isoform A 
in heart and skeletal muscle) probably reflect tissue speci- 
ficities in metabolism and energy requirement. 
4. Topology, human gene and bovine cDNA of the 
citrate carrier 
In order to investigate the topology of the citrate (tri- 
carboxylate) carrier (CIC) in the mitochondrial membrane, 
we have used antibodies against two synthetic peptides 
corresponding to the N- and C-terminal regions of the 
rat-liver mitochondrial tricarboxylate carrier. ELISA tests 
performed with intact and permeabilized rat-liver mito- 
plasts showed that both anti-N-terminal nd anti-C-termi- 
nal antibodies bind only to the cytoplasmic surface of the 
inner membrane [8], indicating that both termini of the 
membrane-bound tricarboxylate carrier are exposed to the 
mitochondrial intermembrane space. Furthermore, tryptic 
digestion of intact mitoplasts markedly decreased the bind- 
ing of anti-N-terminal and anti-C-terminal antibodies to 
the tricarboxylate carrier [8]. These results are consistent 
with an arrangement of the tricarboxylate carrier monomer 
into an even number of transmembrane segments, with the 
N- and C-termini protruding toward the cytosol. 
Like the other mitochondrial carriers, the C1C is en- 
coded by the nuclear DNA. We have determined the 
sequence of the human CIC gene from overlapping e- 
nomic clones generated by PCR using primers and probes 
based upon the rat cDNA [9]. The gene is 2770 nucleotides 
in length and contains eight exons [10]. The seven introns 
interrupt he coding sequence in or near to the extramem- 
brane loops. This finding, already observed in the other 
known genes coding for mitochondrial carriers [5,11-13], 
presumably reflects the course of evolution of the carrier 
genes, which includes two tandem gene duplications of an 
ancestral gene encoding the 100 amino acid repeat, and the 
100 amino acid repeat itself may have arisen by an earlier 
duplication of a single hydrophobic e~-helix. It is worth- 
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while mentioning that, during our investigation on the 
human CIC gene, we have found two human pseudogenes 
related to the CIC gene [10]. The sequences of these two 
pseudogenes, that we determined, encompass the coding 
sequence of the CIC gene between nucleotides 260 and 
720. 
We have also cloned and sequenced the bovine cDNA 
of the CIC. Using primers and probes based on the human 
cDNA sequence, overlapping cDNA clones encoding the 
bovine CIC protein were isolated from total bovine liver 
poly(A +) cDNA. The entire bovine cDNA is 1151 bp in 
length with 5' and 3' untranslated regions of 7 and 211 bp, 
respectively. The open reading frame encodes a protein 
consisting of 311 amino acids. Assuming that the bovine 
CIC precursor is cleaved at the same position as that from 
rat [9], the mature bovine CIC consists of 298 amino acids. 
This sequence differs in 15 amino acids from the mature 
rat CIC [9] and in 14 amino acids from the mature human 
CIC [10]. Out of these differences 3 between cow and rat 
and 4 between cow and man are non-conservatives. 
5. Structure-function relationships of the oxoglutarate 
carrier 
We have continued our studies on the oxoglutarate 
carrier (OGC) by investigating the following aspects: 
5.1. Dimeric structure of the OGC deduced from formation 
of a specific intermolecular disulfide bridge 
We have investigated the ability of the OGC to cross- 
link by using disulfide-forming reagents. We found that 
the isolated OGC [14,15] is cross-linked to dimers by 
Cu2+-phenanthroline or diamide, and that this dimerization 
is increased by acetone or some other solvents [16]. About 
75% of isolated OGC was cross-linked within 10 min and 
the cross-linked OGC, when re-incorporated in proteo- 
liposomes, fully retained the oxoglutarate transport activ- 
ity. In addition, we found that the cross-linking depends on 
the dimeric state of the carrier, i.e., the dimeric state is a 
prerequisite for the cross-linking, since the extent of 
cross-linking did not change on varying the concentration 
of the OGC 10-fold, and dimerization was prevented by 
monomerization and/or degradation of the tertiary struc- 
ture of the OGC. We also showed that cross-linking of 
OGC is accomplished by a single disulfide bond between 
the cysteines 184 of the two monomers. This means that 
the Cys- 184 residues of the two subunits are fairly close to 
each other in the native dimer structure. It is likely that 
these cysteines, localized at the edge of the fourth trans- 
membrane segment of each monomer [17], are not exactly 
opposite ach other at the two-fold axis and possess carce 
mobility, thus explaining why only monomers are found in 
the SDS gels of isolated OGC. In the presence of acetone, 
the probability that Cys-184 of the two monomers of 
preexisting OGC dimers should come into juxtaposition to 
form an S-S bridge increases and consequently a greater 
formation of Cu2+-phenanthroline-induced ross-linked 
OGC is observed. These results add further evidence to the 
hypothesis that the functional units of the members of the 
mitochondrial carrier family are formed by at least two 
monomers. 
5.2. Cys-184 is the binding site of SH reagents 
It has been known for a long time that the function of 
the OGC is inhibited by organic mercurials and not by 
maleimides [18,19]. Using the reconstituted OGC, whose 
activity remains constant over a long period of time, we 
found that maleimides also inhibit the OGC activity when 
the proteoliposomes were incubated with these reagents for 
sufficiently long incubation times. This finding has al- 
lowed us to investigate the reactivity of the SH groups of 
the OGC by using N-(1-pyrenyl)maleimide (PM), which 
irreversibly binds to the OGC and whose complex with the 
OGC is fluorescent. OGC contains three cysteines: Cys- 
184, Cys-221 and Cys-224. In order to identify the cys- 
teine(s) of the OGC labelled by PM, the reconstituted 
liposomes were incubated with PM, after which the carder 
protein was extracted from the vesicles and subjected to 
BrCN cleavage. Direct sequencing of the fluorescent BrCN 
cleavage peptides showed that Cys-184 is the only sul- 
fydryl group of the OGC that is alkylated by PM without 
prior treatment with reducing reagents [20]. Since all the 
other maleimides and mercurials, tested under the same 
experimental conditions, effectively protected the OGC 
against he labelling by PM, we conclude that Cys-184 is 
the site of the isolated and reconstituted cartier where 
SH-reagents bind. 
5.3. Cvs-221 and Cys-224 are linked by a disulfide bridge 
The labelling of only Cys-184 in the reconstituted car- 
rier by PM suggested that the other two cysteines of the 
OGC (Cys-221 and Cys-224) are either linked by a disul- 
fide bridge or have a very low reactivity. To check this 
hypothesis, the reconstituted OGC protein was first treated 
with N-phenylmaleimide (FM) (in order to protect Cys- 184) 
and subsequently with a reducing reagent (in order to 
break the possible disulfide bridge between Cys-221 and 
Cys-224). Thereafter, the carrier protein was extracted 
from the vesicles and labelled with PM. In the samples 
treated only with FM (and not with reducing reagents) the 
labelling of OGC by PM was completely abolished. If 
however, after treatment with FM the reconstituted carrier 
was reduced by 2-mercaptoethanol or dithioerythritol, the 
subsequent addition of PM led to labelling of the protein. 
This labelling was due to the formation of free sulphydryl 
groups, because it was abolished by specific SH-reagents 
such as mersalyl. Moreover, when 2-mercaptoethanol or 
dithioerythritol was added to proteoliposomes without pre- 
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vious treatment with FM, the PM labelling of the carder 
was much greater than the control, i.e., direct labelling by 
PM in the absence of reducing reagent, indicating that the 
addition of 2-mercaptoethanol or dithioerythritol made 
more PM-reacting sites available per protein molecule. 
Furthermore, peptide sequencing showed PM labelling of 
only Cys-184 without preincubation with FM and reducing 
reagents, PM labelling of Cys-22! and/or Cys-224 after 
preincubation with FM and reducing reagents, and finally 
PM labelling of Cys-184 and Cys-221/Cys-224 after 
preincubation only with reducing reagents. Similar find- 
ings were obtained by using purified and SDS-denaturated 
OGC, instead of purified and reconstituted OGC. All these 
results indicate firstly, that PM binds to Cys-184 alone 
when the OGC protein is in the oxidized state, and sec- 
ondly, that PM also binds to at least one of the other 
cysteines (Cys-221 or Cys-224) when the carrier is in the 
reduced state. Additional evidence for the existence of a 
disulfide bridge between Cys-221 and Cys-224 in the 
purified OGC came from measurements of the number of 
the OGC SH groups available to 5,5'-dithiobis(2-nitro- 
benzoate) prior and after treatment with reducing reagents. 
It should be noted that the existence of the proposed 
disulfide bridge is consistent with the earlier prediction 
that Cys-221 and Cys-224 are on the same face of c~-helix 
V of the OGC [17]. 
should be stressed that the enhancing effect of the sub- 
strates was specific, since other chemically related anions, 
which are neither substrates nor inhibitors of the OGC 
[19,22], had no effect. The most likely explanation for the 
effect of the substrates on SH-reagent binding to the OGC 
is that substrate binding induces a change in the tertiary 
structure of the carrier protein which involves the region of 
Cys-184. As a result of the conformational change in the 
carrier, the reactivity or the accessibility of Cys-184 for 
SH-reagents i increased. A higher reactivity of Cys-184 
may be caused by a decrease in the pK of Cys-184, which 
may occur when the microenvironment surrounding the 
sulphydryl group becomes more hydrophilic. In view of 
the putative location of Cys-184 at the border of the 
membrane [17], it is also possible that this residue may 
become more exposed to the water phase. The alternative 
explanation, i.e., that the increased reactivity of Cys- 184 is 
due to an increased accessibility of the sulphydryl group to 
the SH-reagents, is not consistent with the finding that the 
increase in the inhibition induced by the presence of the 
substrates of the OGC is no greater for NEM or FM as 
compared to the bulkier PM. It should be recalled that 
changes in the reactivity of cysteines or other esidues, as a 
consequence of conformational changes induced by sub- 
strate binding, have previously been reported for other 
transport proteins. 
5.4. The reactivity of  Cys-184 to SH reagents" is enhanced 
by substrate binding 
In subsequent experiments he effect of the substrates 
oxoglutarate and malate was analyzed on the binding of 
SH-reagents o the OGC (without pretreatment with reduc- 
ing reagents), i.e., to Cys-184. Liposomes reconstituted 
with the purified OGC were incubated with different SH- 
reagents with and without the two substrates. Care was 
taken to keep the concentration of the sulphydryl reagents 
sufficiently low to obtain only partial transport inhibition. 
Under these conditions, the inhibition of the oxoglutarate 
cartier activity was increased significantly by the addition 
of oxoglutarate or malate during the incubation of the 
proteoliposomes with any of the SH reagents tested. In the 
case of PM, by looking at its fluorescence after binding to 
the OGC in the presence and absence of increasing con- 
centrations of oxoglutarate or malate, we were able to 
show that the substrate-induced increase in the OGC inhi- 
bition is due to an increase in the amount of maleimide 
bound to the carrier [20]. Interestingly, the extent of OGC 
labelling by PM was dependent on the amount of substrate 
present outside the liposomes and not on the presence of 
the substrate inside the liposomes. With both substrates 
oxoglutarate and malate, half maximal increase in transport 
inhibition by SH reagents and half maximal increase in the 
labelling by PM were obtained at a concentration close to 
the half-saturation transport constant (K m) of the reconsti- 
tuted carrier for external oxoglutarate or malate [21]. It 
5.5. Site-directed mutagenesis studies 
In collaboration with Dr. J.E. Walker we succeeded in 
over-expressing the bovine OGC in E. coli and refolding it 
in reconstitutively active form [23]. Mutations were gener- 
ated by the PCR overlap extentive method using the 
expression vector pKN172 containing the bovine OGC 
cDNA as template. The mutated plasmids were employed 
to transform E. coli BL21(DE3) cells. All the expressed 
proteins were purified and reconstituted into liposomes. At 
first the cysteines of the OGC were selected for mutation, 
since they were assumed to play a role in the transport 
mechanism on the basis of chemical modification studies. 
Each cysteine of the OGC has been mutated individually 
(C184S, C221S,  C224S)  or s imultaneously 
(C 184S/C221 S, C 184S/C224S, C221 S/C224S, C-less). 
In all these mutants the affinities for oxoglutarate and 
malate, and the Vma ~ values were not significantly different 
from those measured for the wild-type OGC. These data 
provide direct evidence that the cysteinyl residues of the 
OGC are not essential for transport activity. Labelling 
experiments with PM (see above) showed the absence of 
the disulfide bridge between Cys-221 and Cys-224 in the 
expressed proteins, as normally found for the proteins 
expressed in E. coli. With the exception of the C-less 
mutant, all the other mutants were inhibited by mersalyl 
although with a different efficiency. In particular, higher 
concentrations of mersalyl were required for 50% inhibi- 
tion of C184S/C221S, whose only remaining cysteine is 
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buried deep inside the membrane. Since the sulphydryl 
groups are not involved in the translocation mechanism, 
we think that the binding of SH reagents to each of the 
three cysteines present in the OGC has either an obstruct- 
ing effect on substrate translocation or disturbs some hy- 
drogen bonding. It is interesting that also with the ex- 
pressed OGC, as with the protein purified from mito- 
chondria (see above), the presence of the substrates oxo- 
glutarate and malate during the incubation of the OGC 
with the SH-reagents increased the extent of transport 
activity inhibition. Further experiments with the Cys- 
mutants of OGC confirmed the importance of Cys-184 in 
the substrate-induced enhancement of the inhibitory effect 
of the SH-reagents on the OGC activity. The characteriza- 
tion of the fully active C-less mutant of the OGC provides 
the groundwork for further studies in which site-directed 
Cys replacement in C-less oxoglutarate carrier combined 
with chemical labeling and fluorescence spectroscopy may 
be used to probe the secondary and tertiary structure of the 
oxoglutarate cartier. 
A second group of mutations was directed at the four 
arginine residues located in the putative transmembrane 
a-helices [17]. OGC proteins containing R /L  mutations at 
each individual arginyl residue (R90L, R98L, R190L and 
R288L) were unable to catalyze the oxoglutarate/oxo- 
glutarate xchange. Substitutions of arginines with lysines 
at positions 98 and 180 caused a strong inhibition of 
oxoglutarate transport. By contrast, transport activity was 
substantially retained when arginines at positions 90 and 
288 were individually mutated to lysines. These results 
indicate the primary importance of intramembrane positive 
charges at positions 90, 98, 180 and 288 in the transloca- 
tion mechanism of anionic substrates through the OGC. 
Furthermore they point to a specific requirement for the 
arginyl residues at positions 90 and 180. 
6. Substrate species and reaction mechanism of the 
ornithine carrier 
The omithine carrier (ORC) is the last member of the 
mitochondrial carrier family to have been purified so far. 
The purified protein from rat liver [24] reconstituted into 
liposomes catalyzes an omithine/citrulline xchange, 
which has been characterized kinetically [25]. The or- 
nithine carrier, recently isolated from rat kidney mito- 
chondria by us, shows the same substrate and inhibitor 
specificity found for the liver carrier [24]. The 
omithine/citrulline exchange is very interesting physio- 
logically, because it is involved in the urea cycle. At 
physiological pH, ornithine is positively charged, whereas 
citrulline is neutral. We therefore addressed the question of 
the electric nature of the ornithine/citrulline exchange. 
Experiments performed in proteoliposomes with the puri- 
fied and reconstituted rat liver ORC showed that the 
exchange between ornithine and citrulline is accompanied 
by translocation of H + in the same direction as citrulline, 
i.e., the exchange is electroneutral, H + compensated. 
Among the experimental evidence in favour of this conclu- 
sion we may quote the following: (1) the extent of the 
ornithine/citrulline exchange was not influenced by the 
membrane potential generated by the addition of valino- 
mycin in the presence of K+; (2) with an intraliposomal 
pH of 8, the uptake of citrulline in exchange for internal 
omithine was maximal at external pH 6. Vice versa, with 
the same intraliposomal pH, the uptake of ornithine in 
exchange for internal citrulline was maximal at external 
pH of 8-8.5; (3) the acidification of the intraliposomal 
space, generated by the addition of nigericin in the pres- 
ence of internal K +, stimulated the uptake of ornithine in 
exchange for intraliposomal citrulline; (4) the fluorescence 
of the pH indicator pyranine, included inside the lipo- 
somes, was decreased by the uptake of citrulline in ex- 
change for internal omithine, indicating an influx of H + 
into the vesicles together with citrulline; and (5) vice 
versa, the fluorescence of pyranine was increased by the 
uptake of ornithine in exchange for internal citrulline, 
indicating an effiux of H + from the vesicles together with 
citrulline. 
Further experiments showed that, in addition to the 
ornithine/citrulline exchange, the ORC from liver cat- 
alyzes an omithine/H + exchange although with a lower 
efficiency. The main evidence for this conclusion is the 
effiux of ~4C-ornithine from proteoliposomes in the ab- 
sence of external substrate. With an intraliposomal pH of 
8, this effiux was very low at external pH 8 and was 
increased by decreasing the pH from 8.0 to 5.5. The use of 
uncouplers, nigericin and pyranine (see above) gave results 
consistent with the occurrence of a carrier-mediated or- 
nithine/H + exchange. This exchange is probably neces- 
sary to provide mitochondrial ornithine (not in exchange 
with citrulline) in the cytosol for biosynthetic pathways 
such as the synthesis of polyamines. 
By two-reactant initial-velocity studies (two-substrate 
analysis) varying both the internal and external substrate 
concentrations within the same experiment, we have shown 
that the reconstituted oxoglutarate, citrate and dicaboxylate 
carriers function according to a simultaneous ( equential) 
mechanism, whereas the carnitine carrier proceeds via a 
ping-pong mechanism. We have now studied the kinetic 
reaction mechanism of the ornithine/ornithine and or- 
nithine/citrulline exchanges. We found that the affinities 
of the ORC for the internal and external substrates are not 
influenced by the concentrations of the countersubstrate, 
and that the ratios of Km/Vma x (slopes of Lineweaver-Burk 
plots) decrease as the countersubstrate concentration i - 
creases. On the basis of this and other observations we 
conclude that the ornithine carrier follows a simultaneous 
mechanism, which implies that one internal and one exter- 
nal substrate molecule form a ternary complex with the 
carrier before the transport event occurs. This finding can 
be interpreted by assuming a functional dimer composed 
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of two subunits (each with own binding site for ornithine 
or citrulline) exchanging the two substrates in a concerted 
step between the two compartments. When comparing the 
reaction mechanism of the ORC with those exhibited by 
the other reconstituted mitochondrial carriers investigated 
so far, it seems that all these translocators have a common 
type of kinetic mechanism, with the only exception of the 
carnitine carrier, which is the only one that catalyzes a 
unidirectional transport of substrate in addition to the 
carnitine/acylcarnitine exchange (for Refs. see Refs. [1] 
and [2]). 
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